Abstract:Prostate cancer (PCa) testing is currently based on measurement of serum prostate-specific antigen levels and digital rectal examination, which are limited by a low predictive value and the adverse effects associated with overdiagnosis and overtreatment. Recent studies have reported that the abnormal expression of microRNAs (miRNAs) is associated with the mechanism underlying the development of PCa. Thus, the aim of the present study was to investigate the effects of miR-30e and its target gene, M3 muscarinic acetylcholine receptor (CHRM3), on the adhesion, migration, invasion and cell cycle distribution of PCa cells via the mitogen-activated protein kinase (MAPK) signaling pathway. The differentially expressed genes were screened in the Gene Expression Omnibus database from a gene expression microarray (GSE55945) of PCa. PCa tissues and adjacent tissues were collected from patients with PCa. The PC-3 and DU145 human PCa cell lines were treated with activator, inhibitor and siRNAs. The effects of miR-30e on cell adhesion, migration, invasion and cell cycle distribution with the involvement of CHRM3 and the MAPK signaling pathway were investigated. The bioinformatics results demonstrated that the CHRM3 gene and the MAKP signaling pathway were involved in the progression of PCa, and has-miR-30e was selected for further study. The levels of miR-30e were significantly downregulated, while the levels of CHRM3 were obviously upregulated in PCa. CHRM3 was verified as a target gene of miR-30e. Upregulation of miR-30e and downregulation of CHRM3 decreased the levels of p-P38, p-extracellular signal-regulated kinase, p-c-Jun N-terminal kinase, p-c-fos and p-c-JUN, cell adhesion, migration and invasion ability, and the number of cells in the S phase, while they increased the number of cells in the G0 and G1 phases. The findings of the present study suggest that miR-30e inhibited the adhesion, migration, invasion and cell cycle entry of PCa cells by suppressing the activation of the MAPK signaling pathway and inhibiting CHRM3 expression. Thus, miR-30e may serve as a candidate target for the treatment of PCa.

Monocyte Chemoattractant Protein-1 Modulates Invasion and Apoptosis of Pc-3m Prostate Cancer Cells Via Regulating Expression of Vegf, Mmp9 and Caspase-3

Monocyte Chemotactic Protein-1 (MCP-1) Acts As a Paracrine and Autocrine Factor for Prostate Cancer Growth and Invasion

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone

Monocyte Chemotactic Protein-1 Mediates Prostate Cancer-Induced Bone Resorption

MicroRNA-30e Inhibits Adhesion, Migration, Invasion and Cell Cycle Progression of Prostate Cancer Cells Via Inhibition of the Activation of the MAPK Signaling Pathway by Downregulating CHRM3

Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated with Increased Xenograft Growth and Modification of Immune-Related Microenvironment

Regulation of VEGF, MMP-9 and Metastasis by CXCR4 in a Prostate Cancer Cell Line.

Knockdown of MCM3AP-AS1 Inhibits Proliferation, Invasion and Migration of Prostate Cancer Cells via DNMT1/DNMT3 (A/B) Methylation-Mediated Upregulation of NPY1R

Vascular Endothelial Growth Factor Regulates Myeloid Cell Leukemia-1 Expression Through Neuropilin-1-dependent Activation of C-Met Signaling in Human Prostate Cancer Cells

MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer cells

Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma

Infiltrating T Cells Promote Prostate Cancer Metastasis Via Modulation of FGF11→miRNA‐541→androgen Receptor (AR)→MMP9 Signaling

Low Expression of Microrna-30C Promotes Prostate Cancer Cells Invasion Involved in Downregulation of KRAS Protein.

MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial–mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells

Targeting SMAD3 for Inhibiting Prostate Cancer Metastasis.

LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating Mir-543-3p/slc39a10/pten Axis in Prostate Cancer.

MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells

Effect of the Circcdr1as/mir-641/Xiap Regulatory Axis on the Proliferation and Invasion of the Prostate Cancer PC-3 Cell Line

Mir-137-3p Modulates the Progression of Prostate Cancer by Regulating the JNK3/EZH2 Axis.

Wild-Type P53 Suppresses The Epithelial-Mesenchymal Transition And Sternness In Pc-3 Prostate Cancer Cells By Modulating Mir-145